(Q40081650)

17 September 2017

Mechanisms of cellular resistance to imatinib in human chronic myeloid leukemia cells (English)

1 reference

17 September 2017

chronic myeloid leukemia

0 references

1 reference

1

Yusuf Baran

1 reference

17 September 2017

3

Ufuk Gunduz

1 reference

17 September 2017

2

Ali Ugur Ural

1 reference

17 September 2017

1 December 2007

1 reference

17 September 2017

1 reference

17 September 2017

12

1 reference

17 September 2017

6

1 reference

17 September 2017

497-503

1 reference

STI571 (Gleevec) as a paradigm for cancer therapy

17 September 2017

1 reference

https://api.crossref.org/works/10.1080%2F10245330701384179

Induction of apoptosis in chronic myelogenous leukemia cells through nuclear entrapment of BCR-ABL tyrosine kinase.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10245330701384179

21 January 2018

Chronic myeloid leukemia

1 reference

https://api.crossref.org/works/10.1080%2F10245330701384179

Imatinib mesylate--a new oral targeted therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10245330701384179

Structural mechanism for STI-571 inhibition of abelson tyrosine kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10245330701384179

Interaction of tyrosine kinase inhibitors with the human multidrug transporter proteins, MDR1 and MRP1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10245330701384179

Novel targeted therapies to overcome imatinib mesylate resistance in chronic myeloid leukemia (CML).

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10245330701384179

From MDR to MXR: new understanding of multidrug resistance systems, their properties and clinical significance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10245330701384179

Role of ceramide in mediating the inhibition of telomerase activity in A549 human lung adenocarcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10245330701384179

Defects in cell growth regulation by C18:0-ceramide and longevity assurance gene 1 in human head and neck squamous cell carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10245330701384179

Regulation of the sphingosine-recycling pathway for ceramide generation by oxidative stress, and its role in controlling c-Myc/Max function

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10245330701384179

Clinical resistance to STI-571 cancer therapy caused by BCR-ABL gene mutation or amplification

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10245330701384179

A Bcr/Abl-independent, Lyn-dependent form of imatinib mesylate (STI-571) resistance is associated with altered expression of Bcl-2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10245330701384179

Blockade of the Bcr-Abl kinase activity induces apoptosis of chronic myelogenous leukemia cells by suppressing signal transducer and activator of transcription 5-dependent expression of Bcl-xL

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10245330701384179

Subcellular and submitochondrial mode of action of Bcl-2-like oncoproteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10245330701384179

Bcl-2-independent Bcr-Abl-mediated resistance to apoptosis: protection is correlated with up regulation of Bcl-xL.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10245330701384179

10.1080/10245330701384179

21 January 2018

Identifiers

DOI

1 reference

17 September 2017

1 reference

PubMed ID

17852433